Medifast, Inc. (NYSE:MED) Q3 2019 Earnings Conference Call November 7, 2019 4:30 PM ET Company Participants Katie Turner ??? Investor Relations-ICR, Inc. Dan Chard ??? Chief Executive Officer Tim Robinson ??? Chief Financial Officer Conference Call Participants Linda Bolton Weiser ??? D.A. Davidson Doug Lane ??? Lane Research Stephanie Wissink ??? Jefferies Operator Good afternoon, and welcome to the Medifast Third Quarter Fiscal 2019 Earnings Conference Call. All participants will be in listen-only mode. [ ...

MEDIFAST. % OPTAVIA. INVESTOR PRESENTATION September 2019 Safe Harbor Statement 2 Certain information included in this presentation may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or ...

Medifast, Inc. (NYSE:MED) Q2 2019 Earnings Conference Call August 1, 2019 4:30 PM ET Company Participants Katie Turner - ICR Dan Chard - CEO Tim Robinson - CFO Conference Call Participants Linda Weiser - DA Davidson Steph Wissink - Jefferies Doug Lane - Lane Research Operator Hello, and welcome to the Medifast Second Quarter Fiscal 2019 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to your host today, Katie Turner. P ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) Delaware 13-3714405 (State or other jurisdi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10‑Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 13‑3714405 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 00 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) Delaware 13-3714405 (State or other jurisdiction of incorporation o ...